empty
 
 
ms
Search
Sokongan
Pembukaan akaun segera
Platform dagangan
Deposit/Pengeluaran
Search
Untuk Pedagang baru Untuk Pedagang Untuk Rakan Niaga Berehat sebentar Mengenai InstaSpot
ms
#ALNY Kembali ke senarai instrumen #AUPH

Pertukaran Matawang

Amgen Inc.
279.77 USD
26 Nov 2024 22:59
Perubahan Harga (% chg)
$-0.04
(-0.01%)
Penutupan sebelum
Penutupan sebelum

Harga penutupan bagi hari sebelumnya.
$293.3
Buka
Buka

Harga Pembukaan.
$293.93
Paras Harga Tinggi
Paras Harga Tinggi

Harga tertinggi sepanjang hari terakhir dagangan.
$280.4
Paras Harga Rendah
Paras Harga Rendah

Harga terendah sepanjang hari terakhir dagangan.
$257.69
52 minggu di paras tinggi
52 minggu di paras tinggi

Paras harga tertinggi dalam 52 minggu terakhir
$280.95
52 minggu di paras rendah
52 minggu di paras rendah

Paras harga terendah dalam 52 minggu terakhir
$257.69
Muat turun arkib
Buy
279.77
Sell
279.77
Buka carta dalam paparan skrin penuh
Buy
279.77
Sell
279.77
Muat turun arkib
Buka carta dalam paparan skrin penuh

About Amgen Inc.

Amgen Inc. is one of the world's leading biotechnology companies. Founded in 1980 in the United States, it currently operates in more than 70 countries around the world.

Amgen focuses on developing cutting-edge medicines against cancer, cardiovascular diseases, bone ailments, kidney diseases and other afflictions.

The company currently has a market capitalization of $122.5 billion. Amgen reported revenues of $25.98 billion and a net income of $5.89 billion in 2021.

Amgen Inc. stock and what affects it

The company stock is listed on the NASDAQ exchange under the ticker name AMGN. When the company had its initial public offering in 1983, its shares were priced between $16 and $19 at the time.

Now, Amgen's shares are trading between $227 and $231. Last year, it fluctuated from $198 to $258. Forecasts suggest the stock will continue to climb.

When trading this asset, you have to keep the following things in mind:

  • The company has a dominant position in the market.
  • There are potential opportunities to capitalize on its products and strategic initiatives.
  • Threats to Amgen include its competition, government regulation, and the company’s dependence on wholesale distributors.

Tidak boleh bertanya sekarang?
Tanya soalan anda di Ruangan bersembang.